This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the recent negative opinion from CHMP over Syfovre and the Geographic Atrophy Landscape with a European Retinal Specialist

Ticker(s): APLS

Who's the expert?

Institution: UniSR

  • Associate Professof of ophthalmology at UniSR (Italy).
  • Main focus is on medical retina and ophthalmic surgery.
  • Contributed more than 600 peer-reviewed articles and over 20 books and book chapters as editor/author published mainly in the areas of medical retina disorders.

Interview Questions
Q1.

How do you view the negative opinion of CHMP from Syfovre?

Added By: wilson_admin
Q2.

How enthusiastic are you about Syfovre?

Added By: wilson_admin
Q3.

Would you use Syfovre if it were available?

Added By: wilson_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.